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Abstract 33 
Background:  Vaccination is considered the most effective preventive measure against influenza 34 
transmission, yet vaccination rates during the 2009/10 influenza A/H1N1 pandemic were low across 35 
the world, with the majority of people declining to receive the vaccine.  Despite extensive research on 36 
the predictors of uptake of influenza vaccination, little research has focused on testing the 37 
effectiveness of evidence and theory-based messages. 38 
Aims:  To examine the persuasiveness of messages promoting vaccination and antiviral use either as 39 
health-enhancing or as risk-reducing, as well as messages which conveyed evidence-based 40 
information about the costs and benefits of vaccination, or which applied anticipated regret as a 41 
motivator for vaccine uptake. 42 
Method:  We conducted 11 focus groups with forty-one members of the general population in England 43 
including young and older adults, those with lower  education, parents, and those with elevated health 44 
risk.  The data were analysed using thematic analysis. 45 
Results:  The factual, evidence-based messages were well received with participants finding them the 46 
most convincing and useful, particularly where they gave cost-benefit comparisons. Health-enhancing 47 
messages were received with scepticism and concern that the messages were not honest about the 48 
potential lack of safety of vaccination. In contrast, risk-reduction messages were perceived as being 49 
more balanced and credible. Messages aiming to elicit feelings of anticipated regret for not getting 50 
vaccinated were generally perceived as patronising and unprofessional.   51 
Conclusions:  Vaccination messages should be kept brief, but convey balanced, evidence-based 52 
information, and be transparent in their communication of potential side-effects. The general public 53 
seem to prefer messages that are factual and emphasise the costs and benefits of vaccination, 54 
particularly with regards to vaccine safety.   55 
Keywords: influenza; pandemic; risk communication; vaccination 56 
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1. Introduction 57 
Influenza pandemics arise when little or no immunity to a new virus exists, leading to transmission 58 
and spread of disease (WHO, 2013) and creating levels of uncertainty and unpredictability that have 59 
the potential to severely impact populations worldwide (1, 2). Public health experts consider 60 
vaccination to be the most effective mechanism for minimising the impact of an influenza pandemic 61 
(3), but this relies on public engagement. In the United Kingdom,  many people declined vaccination 62 
during the 2009/10 influenza A/H1N1 pandemic, even among specifically targeted patient groups (4) 63 
and healthcare workers (5, 6) with uptake ranging from 20.8% (the lowest), in those aged 16-25 years, 64 
to 48.2% (the highest), in those aged 60-65 years in a clinical risk group (4). 65 
Research investigating psychological predictors of vaccination uptake found that uptake is associated 66 
with a history of previous vaccination for seasonal influenza (5, 7), perceiving the disease as more 67 
severe (8, 9) and the vaccine as effective and safe (5, 7). Factors reducing vaccination intentions 68 
include scepticism about the level of threat, not perceiving oneself to be at risk, especially if one is 69 
currently healthy, and concerns about vaccination safety and potential negative side-effects (10-14). 70 
Research suggests that these barriers might be addressed by emphasizing the positive benefits of 71 
vaccination (15, 16), while also allaying public concerns about vaccination safety and side-effects. To 72 
increase vaccination uptake during future pandemics, one way to communicate effectively with the 73 
public is to draw on relevant theories of risk communication pertaining to behaviour change. Given 74 
that the lay public relies on social trust to make decisions about risks and benefits particularly when 75 
they lack personal knowledge about a hazard (17), messages advocating vaccination could be made 76 
more transparent and thus trustworthy, e.g. by acknowledging uncertainty around the benefits of 77 
vaccination. Also, given that any situation involving risk can be ‘framed’ in two different but logically 78 
equivalent ways, e.g. lives saved vs. lives lost, attention should be paid to how the risk of pandemic 79 
influenza is communicated. Message framing can impact persuasiveness and thus risk perception, as 80 
highlighted by Prospect Theory (18), with gain-framed messages being more effective than loss-81 
framed messages at encouraging prevention behaviours (19, 20). 82 
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One way to frame precautionary messages is to highlight the reduction of risk vs. the enhancement of 83 
benefits. The main aim of this study was to compare the persuasiveness of messages promoting 84 
vaccination as entailing health benefits (health-enhancing) versus those communicating vaccination 85 
as reducing risk of infection (risk-reducing). Messages conveying health enhancement were expected 86 
to be viewed more positively than messages presenting vaccination as a means of risk reduction (14). 87 
Additionally, we tested messages presenting evidence that the risk of harm from pandemic influenza 88 
is greater than the risk of vaccination side-effects by prompting people to imagine how they might 89 
feel if they refused vaccination and then became ill (anticipated regret), and presenting factual 90 
messages about the relative costs and benefits of vaccination of the A/H1N1 pandemic (transparency). 91 
It was expected that evoking anticipated regret may strengthen the message impact, in light of 92 
research showing that vaccination intentions tend to be stronger when failing to act is associated with 93 
negative emotions that people wish to avoid (27). 94 
Additionally, we examined reactions to messages about antiviral medicines, as besides treatment, 95 
these can play a prophylactic role against pandemic influenza, yet little is known about public attitudes 96 
towards their use. During the A/H1N1 pandemic in 2009/10, Australian research participants were 97 
willing to take a full course of antiviral drugs if exposed to a person with pandemic influenza (21), 98 
while US pregnant and recently pregnant women participating in focus groups indicated being poorly 99 
informed about antivirals and concerned about using them in pregnancy (22). Recent research with 100 
the UK public has indicated that lay people knew little about influenza antivirals, confusing them with 101 
antibiotics, yet viewed antivirals advice as sensible and acceptable (14). 102 
 103 
 104 
2. Methods 105 
2.1 Design 106 
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Eleven focus groups (40-60 minutes) were conducted with 41 members of the UK general public 107 
between October 2014 and July 2015.  We used maximum variation sampling to  include participants 108 
from populations varying in their likelihood to suffer complications as a result of influenza infection, 109 
e.g. parents of babies, younger and older adults,  to examine a variety of views on vaccination.. As we 110 
were particularly interested in assessing the impact of messages on increasing vaccination intentions 111 
amongst non-vaccinators, we recruited wherever possible participants who were not annual influenza 112 
vaccinators (80.5% of our sample). Given the large number of messages to be tested individually 113 
(n=23), we used small-sized focus groups to be able to gauge in-depth the participants’ reasoning 114 
around the messages.  115 
Recruitment was by email and paper adverts through the University of Southampton and community 116 
groups. Each participant received an information sheet explaining the study and that participation was 117 
both confidential and voluntary, and  £10 for participating in the research. Written consent was 118 
obtained before any data collection and ethical approval was granted by the University of 119 
Southampton Ethics Committee. 120 
2.2 Procedure 121 
Participants were presented with a brief, hypothetical scenario describing what might happen during 122 
a pandemic influenza outbreak (Figure 1), including information on health consequences, impact and 123 
vaccination advice. This was based on existing work (14, 15), which involved extensive consultation 124 
with public health and primary care practitioners. Open questions elicited participants’ initial reactions 125 
before a series of messages, each containing four statements, were shown (Table 1). Messages were 126 
designed for dissemination through Twitter and social media networks, as during the A/H1N1 127 
influenza pandemic the public obtained information from social media as well as from official health 128 
sources (23). Two message sets covered vaccination, and two, antiviral medications, with messages 129 
framed both negatively (focus on risk-reduction) and positively (focus on health-enhancement), with 130 
order of message presentation altered for each focus group. Participants were shown two further 131 
message sets: one set of three emotion-focused messaged elicited anticipated regret and one set of 132 
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four factual messages provided cost-benefit information about the A/H1N1 vaccination. Positively- 133 
and negatively-framed messages were based on previous research  showing  that participants denied 134 
being at risk of infection, arguing that they were ‘fit and healthy’, with a strong immune system or 135 
‘healthy lifestyle’ (14, 15). -The emotion-focused messages were developed based on the omission 136 
bias and anticipated regret literature: omission bias refers to perceiving the potential harm from 137 
action (e.g. vaccination) as more negative than the potential harm from inaction (e.g. not getting 138 
vaccinated) (24, 25); anticipated regret refers to the level of regret one expects to feel when choosing 139 
(or not) a particular course of action (26).  The fact-based messages were designed to test whether 140 
transparent, evidence-based information could increase trust and vaccination intentions as suggested 141 
by earlier work (5). After each set of messages, the moderator (first or second author) asked a series 142 
of open questions about participants’ thoughts, reactions, and feelings, about the messages. 143 
Demographic data were collected after each group. 144 
2.3 Data analysis 145 
Focus groups were digitally audio-recorded and transcribed verbatim. Inductive thematic analysis of 146 
each transcript was carried out (27), supported by use of QSR NVivo 10.0 software, and coded into 147 
emerging themes, which represented prevalent patterns of meaning within the dataset  without these 148 
necessarily being highly frequent (28). Analysis was iterative, with two researchers independently 149 
reading and re-reading each transcript. Following consultation, the initial coding structure was revised 150 
to develop a consensus on the codes and themes. Coding followed the aims of the research, focusing 151 
on participants’ reactions to each message set.   152 
3. Results 153 
Thirty-two (78%) women and nine (22%) men participated, with an age range of 19-77 and a median 154 
age of 33 (SD=15.9). Of the participants, 19.5% had regularly received the seasonal influenza 155 
vaccination  since the A/H1N1 pandemic. Full demographic details are available in Table 2. 156 
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Results for vaccination and antiviral messages were combined due to similarity in participant 157 
responses; we highlight differences where present. 158 
3.1 Positively framed, health-enhancing messages 159 
Participants within each group had concerns that the health-enhancing messages (messages 1b-8b) 160 
down-played the severity of the situation, or expressed scepticism surrounding the validity of health-161 
enhancing claims and the seemingly counter-intuitive message that a vaccine could boost the immune 162 
system. Such claims were seen as unfounded given the novelty of the vaccine. For most, scepticism 163 
stemmed from a belief that the messages were misleading, implying that only vaccination or antiviral 164 
treatment could improve health. Several participants mentioned other measures may also improve 165 
health and that further information was needed about how treatments worked: 166 
‘It’ll prevent you from getting flu, but it’s not going to prevent you from getting other infections, 167 
so it’s kind of misleading.’ (FG5, female, 20) 168 
Some participants expressed concerns that the messages seemed too “casual” or “relaxed” for a 169 
pandemic emergency, while others felt that the language and style of the messages seemed more 170 
appropriate for vitamin pills rather than vaccination or antiviral medication. For some, the messages 171 
came across as “pushy” or “intimidating”. Several participants reported feeling that the messages 172 
were implying that their own natural defences or current health state were inadequate:  173 
‘It tells you that maybe your natural defences aren’t good enough. I think mine are fine.’ (FG3, 174 
male, 65)   175 
However, there were some who viewed the messages more positively, feeling that the statements 176 
would not cause alarm or overburden people with medical terminology. They liked how the language 177 
of the messages allowed for personal choice as the tone felt more advisory than threatening. Overall, 178 
participants felt that the messages could be improved through the inclusion of more evidence about 179 
effectiveness and the way treatments work.   180 
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3.2 Negatively framed, risk-reducing messages 181 
Participants had mixed reactions to the risk-reducing messages (messages 1a-8a), i.e., some 182 
participants held ambivalent views on the four risk-reduction messages, liking some more than 183 
others. . However, feedback on the risk-reduction messages tended to be positive, particularly when 184 
compared with the health-enhancing  ones. Messages were found to be clear and convincing, and 185 
written in sensible language that did not feel patronizing or threatening. Language such as ‘reduces 186 
risk’ increased the perceived accuracy and trustworthiness of the message by allowing room for the 187 
admission that vaccination or antiviral medications may not be 100% effective for all people, thus 188 
appearing more open and honest:  189 
‘The ones that say ‘reduce the risk’ are more convincing than the ones that say ‘prevent’. 190 
Everybody’s heard of having the flu jab and still getting ill afterwards, so it’s more convincing.’ 191 
(FG2, female, 30) 192 
Focusing on risk reduction provided participants with more information about the consequences of 193 
refusing vaccination, which they felt would help them to make a decision regarding treatment uptake.  194 
For others, the message that being vaccinated or taking antivirals would prevent the spread of illness 195 
to their family or colleagues was the most persuasive:  196 
‘…my concern is spreading it to my parents at some point because they’re less likely to be able 197 
to fight it off successfully without complications.’ (FG1, female, 30) 198 
Negative evaluations of the risk-reducing messages were less common, but were discussed by all 199 
groups and were more evident in relation to the antiviral messages than the vaccination messages.  200 
Several of the antiviral messages were aimed at those in a 'priority group’, e.g. people with an 201 
underlying health condition (messages 5a & 8a), which some participants reported finding worrying 202 
as they did not know if this related to them, or because it sounded like special treatment being 203 
reserved for some groups.  204 
3.3 Emotion-focused, anticipated regret messages 205 
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The message comparing the risk of experiencing vaccination side-effects to the risk of harm from 206 
pandemic influenza (message 11) was the most popular as participants liked the way the message 207 
showed two sides to the issue: acknowledging that vaccination side-effects are possible, yet weighing 208 
these against the risk of contracting influenza:  209 
‘That statement does say the risk of side-effects, but it says the risk of harm from flu is higher 210 
than the risk of side-effects, which sort of minimises the possibility.’ (FG3, female, 67) 211 
Although participants preferred the risk comparison message over others, many reported that they 212 
only liked this section of the statement and would change or remove the section that explicitly 213 
mentioned regret. Across all groups, participants largely  disliked the use of the terms ‘regret’ and 214 
‘upset’ within messages which they considered “unprofessional” and “less authoritative”, and not 215 
necessarily reflecting how they would respond emotionally:  216 
‘I think [the statement] is a bit patronizing, I don’t want to be told when I’m likely to feel upset 217 
about something.’ (FG7, female, 35) 218 
The majority of participants also disliked the message which mentioned a small risk of unknown, long-219 
term effects from vaccination (message 9), as this would provoke fear or alarm, reduce levels of trust, 220 
and draw attention away from the positive aspects of vaccination. Participants generally reported that 221 
they would like more detailed information about potential side-effects, although a couple mentioned 222 
finding this unnecessary as it could make vaccination sound “too risky”. In addition, participants 223 
mentioned that the most trusted and credible information source during a pandemic would be health 224 
authorities such as the UK’s Department of Health, and that they would not expect to receive these 225 
emotion-focused messages from professional sources. 226 
3.4 Fact-focused messages 227 
Balanced messages presenting the risks and benefits of the past A/H1N1 pandemic were generally 228 
well received due to their inclusion of factual information (messages 12-15), as the facts and numbers 229 
made the messages more striking and convincing, particularly as it appeared that they were providing 230 
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“evidence” and not just unsubstantiated “advice”. Several participants spoke about preferring these 231 
messages to others as the amount of information included enabled them to make their own decision 232 
about vaccination or treatment:  233 
‘They don’t feel manipulative. It feels just like you’re being sent information for you to be able 234 
to make your own decision.’ (FG7, male, 36) 235 
The statistical information gave participants a reference point from which to make more meaningful 236 
judgements about the risk and severity of both the pandemic threat and the vaccination. In addition, 237 
several participants felt that the messages were made more compelling by focusing on the impact of 238 
the A/H1N1 pandemic on children, as they could have the potential to invoke stronger emotions in 239 
others (e.g. fear), particularly those with children, although they did not necessarily elicit stronger 240 
emotions. There were no gender-specific responses to these fact-based child-focused messages 241 
among the participants.   242 
Some participants found the factual messages less accessible, saying the statistics might confuse 243 
people and mentioning side-effects such as narcolepsy could cause concern as not everyone would 244 
understand such terms.  It was considered preferable to avoid mentioning serious side-effects as these 245 
may discourage some people from getting vaccinated. There was also some scepticism about the 246 
messages, particularly the claim that vaccination would have saved the lives of children who died 247 
during the A/H1N1 pandemic (message 14).   248 
4. Discussion 249 
This study offers novel insights into how the general public may be likely to respond to messages 250 
advocating vaccination and antiviral medicines. Participants largely preferred the risk-reducing 251 
messages, perceiving them as more balanced and credible, particularly when compared to health-252 
enhancing messages, which elicited greater scepticism. Factual, evidence-based messages 253 
emphasising the costs and benefits of vaccination were well received, while emotion-focused 254 
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messages explicitly aiming to evoke feelings of anticipated regret were generally seen as patronising 255 
or unprofessional.  256 
Previous research indicates that those who view themselves as healthy are less likely to accept 257 
influenza vaccination (14, 16, 29, 30). Despite our aim to reinforce healthy identities by framing 258 
vaccination as a way to maintain or improve health in the health-enhancing messages, we found that 259 
these were unexpectedly perceived as challenging participants’ existing perceptions of themselves as 260 
healthy. The present vaccination messages served as the basis of a companion study employing an 261 
online experimental design which found that the health-enhancing messages were as effective in 262 
promoting vaccination intentions as those framed as risk-reducing (31). . Perhaps this difference can 263 
be explained by focus group participants spending greater time critically reflecting on each message 264 
in order to engage in discussion, compared with the online experiment where participants may have 265 
engaged with the messages in a more cursory and/or passive manner. This corroborates research 266 
showing that when more time is spent carefully evaluating messages, negatively phrased information 267 
is perceived as more convincing than equivalent positively phrased information (32).   268 
Participants often reported perceiving the risk-reduction messages as more credible and balanced, 269 
suggesting that presenting health messages positively may not be advisable when uncertainty exists 270 
around the effectiveness of recommended behaviours (33). Some participants viewed the mention of 271 
risk in the risk-reduction messages as acknowledging that vaccination could not guarantee good health, 272 
whereas the health-enhancing messages appeared ‘one-sided’ due to focusing only on how 273 
vaccination can improve health. This links to earlier research showing that two-sided messages are 274 
viewed more credibly (34), and highlights the importance of directly addressing vaccination concerns 275 
(15). 276 
Participants largely perceived the messages aiming to evoke feelings of anticipated regret as 277 
patronising.  Previous studies examining the impact of anticipated regret on various health behaviours 278 
have produced inconsistent results, such as studies investigating the role of anticipated regret in 279 
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vaccination intentions (26).  A review of the literature on inducing regret (35) suggests that strong pre-280 
intervention intentions to engage in a behaviour (36) and a lack of defensive resistance (37) may 281 
predict the success of anticipated regret as a driver of behaviour change. Therefore, the rejection of 282 
our messages may be explained by our purposive sampling of people who had not previously been 283 
vaccinated, and who were thus likely to have weak vaccination intentions. It may also be possible to 284 
induce regret less explicitly, which may be viewed more positively by the public.  285 
4.1 Recommendations 286 
The present findings, albeit based on a small sample of participants, suggest that transparent and 287 
balanced messages  have the potential to encourage the general public to vaccinate during a pandemic 288 
influenza outbreak, and we propose several ways to do so. First, messages could incorporate more 289 
evidence-based information, particularly in relation to the safety of vaccines or antiviral medicines. 290 
Messages that present vaccination costs and benefits, or compare risks posed by vaccination to those 291 
posed by contracting pandemic influenza, allow people greater opportunity to feel that they have 292 
control over their own health. Indeed, previous research has demonstrated that appraising one’s 293 
ability to cope with a given health threat, including cost-benefit perceptions, are an important 294 
predictor of intentions and behaviour (38, 39). Uncertainty surrounding pandemic emergence and 295 
vaccine development can affect the public’s willingness to vaccinate (40), so it is imperative that 296 
communicators provide certainty wherever possible, while also being transparent about where 297 
uncertainty exists and why. Our present findings on the positive reactions to the transparent, fact-298 
based messages warrant further research on how to improve trust in risk communicators as a 299 
precursor of vaccination acceptance.  Given that the public prefer health advice from official health 300 
authorities (41), communicators should think about how to build trust by challenging existing 301 
misconceptions about pandemic influenza and vaccination, as well as the governance of their risks. 302 
Finally, this study illustrates that public health messages may not always be received as intended (42), 303 
suggesting that further work into the impact of emotion-focused messaging could be beneficial.  304 
4.2 Limitations 305 
RUNNING HEAD: COMMUNICATING TO INCREASE PUBLIC UPTAKE OF FLU VACCINATION 
 
13 
 
This study employed a relatively small sample and as such cannot be held to represent the views of 306 
the general public. Nor could we draw any conclusions to reflect the views of any specific sub-group, 307 
e.g. mothers of young babies. Yet, we believe our study has ‘information power’ (43), as the study aim 308 
was narrow, the study design was informed by theory, the participant sample was dense, and the 309 
quality of the dialogue was strong. We would have preferred to include a greater number of men, 310 
older adults and patients with chronic health conditions, but  in line with previous findings (44, 45),  311 
many  who expressed interest to participate were ineligible. Further research with these populations 312 
is needed to ensure generalisability of the present results Opportunity sampling was used due to time 313 
and monetary constraints, but future research should sample a wider swathe of the UK public to 314 
increase representativeness. Furthermore, we used a scenario to elicit behavioural intentions. 315 
Although behaviour can only be directly measured during a pandemic, it is important to note that 316 
intentions are not always a completely accurate indicator of behaviour (46). For example, the 317 
emotional impact of messages may have direct effects on behaviour that are not accessible to 318 
participants’ awareness.  319 
4.3 Conclusions 320 
Pandemic influenza communication should convey transparent, evidence-based information. The 321 
general public appear to prefer factual messages that emphasise the costs and benefits of vaccination, 322 
particularly with regards to vaccine safety. It would also be advantageous to challenge existing 323 
misperceptions and address topics of uncertainty where possible. Although it is not feasible to pre-324 
test messages for all potential pandemic situations and populations, it remains important to test the 325 
key components of messaging as this is the best way to ensure maximum effectiveness and reduce 326 
the chances of unintentional, negative impacts.  327 
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Figure 1. Pandemic influenza scenario text 458 
 459 
 HEALTH CONSEQUENCES: A new strain of flu virus is now spreading throughout the world and a 460 
pandemic flu outbreak has been declared. Most people who catch pandemic flu will feel very ill 461 
for many days, with high fever, severe chills, muscle pain and headache. Some people who catch 462 
pandemic flu will have no symptoms but will however transmit the infection to others around 463 
them and thus keep the virus in circulation. Around 1 in every 100 people who catch this flu 464 
become so ill that they need hospital care, and about 1 in every 1000 infected people die. 465 
 IMPACT: At this point, scientists do not yet know how badly the flu virus will affect people in the 466 
UK - doctors are trying to learn about the virus as fast as they can, but do not know if the pandemic 467 
will be mild or serious. When the virus spreads widely across the UK, we don’t know whether life 468 
will carry on much as usual or whether there will be serious problems with services such as the 469 
NHS, schools and vital supplies. Health care may need to be prioritised for the most seriously ill. 470 
Other essential services (e.g. postal service, refuse collection, fire & police services, public 471 
transport and shops) may be disrupted, too, if people are absent due to flu illness. 472 
 VACCINATION ADVICE: A new vaccine has been developed and pandemic flu vaccination is 473 
advised for all members of the general public, including children over six months of age. You will 474 
be invited to go to an immunisation clinic or to make an appointment at your surgery. If you don’t 475 
hear from your GP surgery, get in touch with them and arrange a vaccination appointment. 476 
 477 
  478 
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Table 1.  Messages seen by participants  479 
Vaccination Messages 
Risk-reducing Health-enhancing 
1a. By getting vaccinated against pandemic flu, 
you will prevent the infection from spreading to 
your family and work colleagues. 
1b. Getting vaccinated against pandemic flu will 
help you stay healthy, active, and able to look 
after your family during the current pandemic. 
2a. Have the pandemic flu jab today! It will 
prevent you from becoming infected and 
seriously ill with flu. 
2b. Getting vaccinated against pandemic flu will 
strengthen your body’s natural defences. 
3a. You should get vaccinated to protect 
yourself from getting pandemic flu. Vaccination 
will reduce your risk of infection.  
3b. You should get the pandemic flu 
vaccination. Vaccination will boost your natural 
immune system. 
4a. Getting vaccinated against pandemic flu 
reduces your chances of becoming infected and 
developing complications if you were to catch 
flu. 
4b. Have the pandemic flu jab today! It will help 
you maintain healthy levels of antibodies. 
Antiviral Messages 
Risk-reducing Health-enhancing 
5a. If you are in a priority group, taking antiviral 
medicines will reduce your risk of catching flu. 
5b. If you are prescribed antiviral medicines, 
you should take the full course to stay healthy, 
active, and able to look after your family. 
6a. Only by taking a full course of antiviral 
medicines like Tamiflu will you reduce your risk 
of becoming infected and seriously ill with flu. 
6b. If you are prescribed antiviral medicines by 
your GP, taking them will boost your body’s 
natural defences. 
7a. If you are in a priority group, taking antiviral 
medicines will prevent the infection from 
spreading to your family and work colleagues. 
7b. Only by taking a full course of antiviral 
medicines like Tamiflu will you maintain healthy 
levels of antibodies. 
8a. If you are prescribed antiviral medicines, 
you should take the full course to reduce your 
chances of becoming infected with pandemic 
flu. 
8b. If you are recommended antiviral medicines 
by your GP, taking them will boost your natural 
immune system. 
Emotion-focused, anticipated regret messages 
9. In this emergency situation it is essential to be vaccinated even though there may be a small 
risk of long-term side effects we don’t know about. 
10. You are more likely to feel upset if you got pandemic flu and had not been vaccinated, than 
feel upset if you got vaccinated. 
11. Nobody wants to do something they may regret, but the risk of harm from flu is much higher 
than the risk of side effects from vaccination. 
Fact-focused, A/H1N1 legacy messages 
12. In the last pandemic, a large number of children were affected by swine flu. 11 children died 
out of every 100,000 children infected. 
13. In the swine flu pandemic of 2009-2010, 70 children died. This is greater than the number of 
children who die from leukaemia each year. 
14. The children who did die from swine flu had not been vaccinated against swine flu. 
Vaccination would have saved their lives. 
15. About 1 million children were vaccinated against swine flu. While 11 experienced side effects, 
such as narcolepsy, none of them died. 
 480 
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Table 2. Demographic characteristics of the sample (n=41) 482 
Demographic characteristics 
Number / Proportion 
of the sample n (%) 
Gender   
Female 32 (78.0%) 
Male 9 (22.0%) 
Age   
16-24 years 12 (29.3%) 
25-34 years 12 (29.3%) 
35-44 years 8 (19.5%) 
45-54 years 3 (7.3%) 
55-75 years 6 (14.6%) 
Ethnicity   
White  28 (68.3%) 
Other  12 (29.3%) 
Prefer not to answer 1 (2.4%) 
Education   
Secondary education 8 (19.5%) 
Further education 3 (7.3%) 
College or university 30 (73.2%) 
Location  
Rural area or village 16 (39.0%) 
Large town or city 25 (61.0%) 
Children under 18 
Yes 
 
16 (39.0%) 
No 25 (61.0%) 
Perceive self to be at high risk of contracting flu   
Yes 14 (34.1%) 
No 
 
27 (65.9%) 
Regularly vaccinate for seasonal flu since A/H1N1  
Yes  8 (19.5%) 
No 33 (80.5%) 
Was vaccinated during A/H1N1 pandemic  
      Yes 5 (12.2%) 
      No 33 (80.5%) 
      Can’t remember 3 (7.3%) 
Took antivirals during A/H1N1 pandemic  
      Yes 4 (9.8%) 
      No 32 (78.0%) 
      Can’t remember 5 (12.2%) 
 483 
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Supplementary Material:  485 
Focus Group Coding Structure 486 
- Antiviral experiences 487 
- Concern about spread (rate, mode, etc.) 488 
- Concern for others (family, friends, colleagues) 489 
- Dislike health enhancing messages 490 
o Pushy, patronising 491 
o Scepticism, distrust 492 
- Dislike fact-focused messages 493 
- Dislike risk reduction messages 494 
o Confidence 495 
o Contradictory 496 
o Lack of information 497 
- Dislike emotion focused messages 498 
o Alarmist 499 
o Lack of information 500 
o Scepticism 501 
- Distrust of pharma 502 
- Importance of choice 503 
- Information wanted 504 
- Knowledge  505 
- Like health enhancing messages 506 
- Like fact-focused messages 507 
o Factual and statistics 508 
o Gives perspective 509 
- Like risk reduction messages 510 
o Social responsibility 511 
o Trustworthy 512 
- Like emotion focused messages 513 
- Likelihood of taking antivirals 514 
- Media impact 515 
- Message source and audience 516 
- Other protective measures 517 
- Perceived severity and risk 518 
- Perceptions of previous pandemics 519 
- Preferred messages 520 
- Psychological impact 521 
- Scenario response 522 
- Seek information 523 
- Social media use 524 
- Treatment of children 525 
- Treatment pressure 526 
- Trust in healthcare workers 527 
- Vaccination barriers 528 
o Effectiveness concerns 529 
o Not ‘at risk’ 530 
o Not for everyone 531 
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o Perceptions of risk or severity 532 
o Safety concerns 533 
- Vaccination beliefs 534 
- Vaccination drivers 535 
o Avoid disruption 536 
o Being ‘at risk’ 537 
o Concern about spread 538 
o Employer views 539 
o Past experience 540 
o Right thing to do 541 
- Vaccination experiences 542 
- Vaccination intentions (yes, no, delay, unsure) 543 
- Vaccine or treatment access 544 
- Vaccine versus antivirals 545 
